Sanofi and GSK to seek approval for delayed Covid-19 vaccine
Sanofi and GlaxoSmithKline (GSK) plan to seek regulatory authorisation for their Covid-19 vaccine after reporting positive results from a late-stage…
Sanofi and GlaxoSmithKline (GSK) plan to seek regulatory authorisation for their Covid-19 vaccine after reporting positive results from a late-stage…
Moderna is aiming to market a Covid-19 and influenza booster vaccine combo within the next two years, CEO Stéphane Bancel…
The first oral antiviral to treat Covid-19, Merck and Ridgeback Biotherapeutics’ molnupiravir, has been approved by the UK drugs regulator.…
Merck and Ridgeback Biotherapeutics’ antiviral of the moment, molnupiravir, appears likely to become the first oral treatment approved for Covid-19,…
The trillions of micro-organisms found in the human body, known collectively as the microbiome, contain a wealth of genetic information…
Chinese clinical-stage company Clover Biopharmaceuticals has announced that its protein-based Covid-19 vaccine candidate, SCB-2019, was 67% effective against coronavirus infection…
Despite being founded just last June, Belgian biotech ExeVir is making serious headway in the race to develop effective antibodies…
University of Oxford scientists behind the AstraZeneca (AZ) Covid-19 vaccine have begun trialling a new plague vaccine in participants. The…
Scientists have been searching for drugs to repurpose for Covid-19 since the pandemic began, and researchers in India are exploring…
Since the outbreak of Covid-19 worldwide, scientists and pharmaceutical companies alike have raced to find ways to protect against and…